Tatum, PsyD , MS, instructor in the department of social and behavioral sciences at Virginia Commonwealth Universitys School of Public Health
Our findings help address existing concerns that have limited the inclusion of this population in randomized controlled trials and move the needle towards favorable consideration of GLP-1 RAs as a therapeutic option in this population
Use of GLP-1 medications Source: Montero, et al KFF, November 14, 2025 KFF published survey data showing that one in 12 American adults report that they are currently taking GLP-1 medications
Cardiovascular disease : The most robust evidence for anti-inflammatory benefits comes from cardiovascular outcomes trials
If you experience severe symptoms, seek medical care promptly
Members are encouraged to build strength, protect muscle, stay nourished, and develop habits that support long-term health even after weight loss slows